Lancet 392:21802193 Guzman CB, Zhang XM, Liu R et al (2017) Treatment with LY2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes
"Peptides need to be from a physician and a compounding pharmacist, and not, from what I've heard, a business card in the men's bathroom," said Elizabeth Yurth, co-founder of the Boulder Longevity Institute
The use of long-term, low-dose erythromycin in treating persistent gastric stasis
TET hydroxylase activity decreased along with Tet1 gene expression
Personalized, supervised dosing produces steadier, safer outcomes, while chasing a larger dose from an unverified source raises risk without improving results
Not suitable for vegetarians or vegans due to the gelatin capsule